CannTrust Ontario facility gets non-compliant rating from Health Canada

CannTrust shares plunge again as Health Canada deems 2nd cannabis facility 'non-compliant'

CannTrust shares plunge again as Health Canada deems 2nd cannabis facility 'non-compliant'

About 6.75M shares traded or 60.85% up from the average.

Its the second recent instance where CannTrust was found by Health Canada to be operating in non-compliant facilities. When considering these forward-looking information and statements, readers should keep in mind the risk factors and other cautionary statements in CannTrust's Annual Information Form dated March 28, 2019 (the "AIF") and filed with the applicable Canadian securities regulatory authorities on SEDAR at and filed as an exhibit CannTrust's Form 40-F annual report under the United States Securities Exchange Act of 1934, as amended, with the United States Securities and Exchange Commission on EDGAR at

It more recently dropped 50% in a matter of weeks following the initial finding that it was growing marijuana in unlicensed rooms.

CannTrust continued to slide on Monday after Health Canada deals the company yet another blow.

The wild ride for CannTrust Holdings Inc. shareholders continued Monday morning after the company's stock plunged on news that its manufacturing facility in Vaughan, Ont., has been rated non-compliant by Health Canada. "As previously announced, the Company implemented a voluntary hold on the sale and shipment of all cannabis products while Health Canada reviewed its Vaughan, Ontario manufacturing facility", the company said in a statement.

After the market closed on Friday, CannTrust Holdings Inc.

Ebola outbreak: Scientists believe they've found life-saving drug according to study results
He said: 'Thanks to this trial, we are starting to understand which treatments to offer to patients in this and future outbreaks'. On the other hand, 33% of participants who received remdesivir and 24% of participants who received ZMapp died.

Health Canada has told CannTrust that it's unable to provide any guidance about the timing or content of its decisions regarding the company.

Markets Insider is looking for a panel of millennial investors.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Not too long ago, CannTrust was frowned upon by Health Canada, as the former was supposedly growing cannabis without the necessary licenses. The company ousted its CEO after the incident.

Since Health Canada found the unlicensed pot cultivation, CannTrust fired Peter Aceto as chief executive officer, while Eric Paul resigned as chairman. (NYSE:CTST) news were published by: which released: "CTST CLASS ACTION UPDATE: Hagens Berman Updates CannTrust (CTST) Investors, Encourages Investors Who Suffered $50,000+ Losses to Contact the Firm - PRNewswire" on July 15, 2019, also with their article: "Zhang Investor Law Reminds Investors of September 9 Deadline in Securities Class Action Lawsuit Against CannTrust Holdings Inc. â€" CTST - GlobeNewswire" published on August 07, 2019, published: "Is This Cannabis Stock a Better Buy Than Canopy Growth Corp (TSX:WEED)?

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.